GALENAGEN has determined that one of its formulations can potentially have efficacy in treating COVID19. While it is an early determination, Galenagen is embarking on clinical trials under an FDA IND. In this time of great medical need. It is imperative for companies like Galenagen to do our part during the Pandemic.
Clinical investigators, hospitals or clinical sites interested in joining the CoGEN-2 clinical trials should email Contact@Galenagen.com.
GALENAGEN COVID19 RESPONSE